Ergoteles LLC Next Cure, Inc. Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.2 - $3.07 $21,091 - $53,958	17,576 New	17,576 $24,000
Q4 2021 Feb 14, 2022	SELL	$5.7 - $9.1 $409,830 - $654,290	-71,900 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.74 - $8.02 $21,568 - $25,664	-3,200 Reduced 4.26%	71,900 $485,000
Q2 2021 Aug 12, 2021	BUY	$7.6 - $10.28 $570,760 - $772,028	75,100 New	75,100 $603,000

15.9M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $36.4M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.